SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S5 - General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): General Neurology
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
2:35 PM - 3:00 PM Discussion Na Tosha Gatson MD, PhD 

Disclosures

Speaker Disclosure
Na Tosha N. Gatson, MD, PhD Dr. Gatson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novocure (Optune).

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Impact of NEOD001 on Neuropathy in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From the Expansion Phase of a Phase 1/2 Study Michaela Liedtke
Disclosure:
Dr. Liedtke has received personal compensation for activities with Prothena, Amgen, Takeda, and Pfizer as a consultant or advisor. Dr. Liedtke has received research support from Prothena, Amgen, Takeda, Pfizer, Celgene, and Novartis.

1:12 PM 002 Corticokinematic coherence is decreased in patients with Friedreich Ataxia and correlates with GAA1 expansion Gilles Naeije
Disclosure:
Dr. Naeije has nothing to disclose.

1:24 PM 003 Long-Term Risk of Seizures in Survivors of Sepsis Michael Reznik, MD
Disclosure:
Dr. Reznik has nothing to disclose.

1:36 PM 004 Impact of Neurological Magnetic Resonance Imaging in Non-Approved Cardiac Devices Lina Ya'qoub
Disclosure:
Dr. Ya'qoub has nothing to disclose.

1:48 PM 005 Resting cerebral perfusion impairment in Type 2 Diabetes Weiying Dai
Disclosure:
Dr. Dai has nothing to disclose.

2:00 PM 006 Clinical features of post-vaccination Guillain-Barrè Syndrome (GBS) in the Republic of Korea Bum Chun Suh
Disclosure:
Dr. Suh has nothing to disclose.

2:12 PM 007 Specific human antisense oligonucleotide (ASO) targeting TGF-ßRII rescues proliferation of TGF-ß arrested human neuronal progenitor cells (ReNcell CX) Sabrina Kuespert, PhD
Disclosure:
Dr. Kuespert has received personal compensation for activities with NeuroVision Pharma GmbH, Germany.

2:24 PM 008 Glia maturation factor inhibits mitochondrial biogenesis, increase oxidative stress and apoptotic cell death in dopaminergic neurons Govindhasamy Pushpavathi Selvakumar
Disclosure:
Dr. Selvakumar has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C2 Functional Neurologic Disorders I: Movement, Seizures, and Speech Disorders Alberto Espay MD, FAAN
7:00 AM-4:00 PM
C6 Neurology MOC Prep Course Nicholas Johnson MD
9:30 AM-11:30 AM
C8 Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C12 Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
12:00 PM-1:00 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
1:30 PM-3:30 PM
C22 Critical Care Consultations for Neurohospitalists Vanja Douglas MD
4:15 PM-5:30 PM
PL1 Hot Topics Plenary Session

Wednesday April 25, 2018

7:00 AM-9:00 AM
C138 Neurologic Case Studies in Pregnancy Mary O'Neal MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C143 Neurology Update I: Epilepsy, Behavioral Neurology, and Neurologic Infections Ralph Jozefowicz MD, FAAN
C147 LGBTQI Health in Neurology Holly Hinson MD, MCR
3:30 PM-5:30 PM
C159 Neurology Update II: Movement Disorders, Spine Disorders, and Sleep Disorders Ralph Jozefowicz MD, FAAN
C167 CNS Toxicities Neeraj Kumar MD

MEMBER LOG IN

Forgot Password?